Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 31, 2019
Patent Application Number
15978695
Date Filed
May 14, 2018
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
Provided are antibodies that specifically bind to Programmed Death-1 (PD1, Pdcd-1, or CD279) and inhibit PD1-mediated cellular signaling and activities in immune cells, antibodies binding to a set of amino acid residues required for its ligand binding, and uses of these antibodies to treat or diagnose cancer, infectious diseases or other pathological disorders modulated by PD1-mediated functions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
